PenumbraMEX:PEN 89 Piotroski F-Score is 7 as of Jun. 26, 2026, which is 40% above its 10-year median of 5.00. GuruFocus rates MEX:PEN with a GF Score™ of 89/100 and a GF Value™ of MXN4,981.98. The stock has 1 warning sign investors should review. Among 805 Medical Devices & Instruments companies, Penumbra ranks better than 92.42% on this metric.
Good Sign:
Piotroski F-Score is 7, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Penumbra has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Penumbra's Piotroski F-Score or its related term are showing as below:
MEX:PEN'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 5 Max: 9
Current: 7
During the past 13 years, the highest Piotroski F-Score of Penumbra was 9. The lowest was 2. And the median was 5.
Penumbra (MEX:PEN) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Penumbra Piotroski F-Score Related Terms
Penumbra Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Penumbra's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:PEN vs GMED, PODD, MASI: Piotroski F-Score Comparison
For the Medical Devices subindustry, Penumbra's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Penumbra Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Penumbra's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Mar26) TTM:
Last Year (Mar25) TTM:
Net Income was 852.398 + 841.1 + 852.444 + 587.577 = MXN3,134 Mil. Cash Flow from Operations was 846.297 + 1068.788 + 1557.205 + 1568.322 = MXN5,041 Mil. Revenue was 6391.666 + 6506.413 + 6939.127 + 6757.899 = MXN26,595 Mil. Gross Profit was 4217.929 + 4410.239 + 4719.798 + 4569.685 = MXN17,918 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(32596.193 + 31535.314 + 31999.054 + 32887.753 + 34233.963) / 5 = MXN32650.4554 Mil. Total Assets at the begining of this year (Mar25) was MXN32,596 Mil. Long-Term Debt & Capital Lease Obligation was MXN3,600 Mil. Total Current Assets was MXN22,999 Mil. Total Current Liabilities was MXN3,818 Mil.
Net Income was -1102.87 + 581.395 + 702.483 + 802.432 = MXN983 Mil.
Revenue was 5485.094 + 5927.548 + 6580.349 + 6631.321 = MXN24,624 Mil. Gross Profit was 2983.044 + 3944.085 + 4394.734 + 4416.578 = MXN15,738 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(26219.51 + 28113.316 + 29124.376 + 31975.563 + 32596.193) / 5 = MXN29605.7916 Mil. Total Assets at the begining of last year (Mar24) was MXN26,220 Mil. Long-Term Debt & Capital Lease Obligation was MXN4,211 Mil. Total Current Assets was MXN20,452 Mil. Total Current Liabilities was MXN3,245 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Penumbra's current Net Income (TTM) was 3,134.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Penumbra's return on assets of this year was 0.09613144. Penumbra's return on assets of last year was 0.03750795.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Penumbra's gearing of this year was 0.11026303. Penumbra's gearing of last year was 0.14224859.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Penumbra's current ratio of this year was 6.02370876. Penumbra's current ratio of last year was 6.30214397.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Penumbra's number of shares in issue this year was 39.544. Penumbra's number of shares in issue last year was 39.163.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Penumbra's gross margin of this year was 0.67371988. Penumbra's gross margin of last year was 0.63914236.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Penumbra's asset turnover of this year was 0.81589605. Penumbra's asset turnover of last year was 0.93915989.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
0
+
0
+
1
+
0
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Penumbra has an F-score of 6 indicating the company's financial situation is typical for a stable company.
Penumbra (MEX:PEN) has a Piotroski F-Score of 7 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Penumbra and its competitors. This is 40% above median its historical median of 5.00. Over the past decade, Penumbra's Piotroski F-Score has ranged from 2.00 to 9.00. According to the industry distribution chart, Penumbra ranks #61 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 7.6%.
Is Penumbra's Piotroski F-Score too high?
Penumbra's current Piotroski F-Score of 7 is 40% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 9.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Penumbra's value of 7 is 40% above this industry median. Based on the distribution chart, Penumbra ranks #61 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Penumbra has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Piotroski F-Score compare to GMED and PODD?
According to the Medical Devices & Instruments industry distribution chart, Penumbra ranks #61 out of 805 companies for Piotroski F-Score. This places Penumbra in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Penumbra's value of 7 is 40% above this benchmark. Historically, Penumbra's own Piotroski F-Score has ranged from 2.00 to 9.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Penumbra has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Penumbra's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Penumbra and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Penumbra's current Piotroski F-Score is 7, which is 40% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Penumbra (MEX:PEN) has a current Piotroski F-Score of 7. The stock's GF Value™ is MXN4,981.98, compared to a current price of MXN4,775.70 — trading 4.1% below its estimated fair value. The current Piotroski F-Score is 7, which is 40% above median its 10-year median of 5.00 and 40% above the Medical Devices & Instruments industry median of 5.00. Penumbra's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Penumbra (MEX:PEN), the current Piotroski F-Score is 7 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Penumbra (MEX:PEN) Overvalued in 2026?
Based on GuruFocus' analysis, Penumbra stock appears to be undervalued.
The current stock price of MXN4,775.70 is trading 4.1% below its estimated GF Value™ of MXN4,981.98.
Key valuation signals for MEX:PEN:
Piotroski F-Score: 7 (40% above median its 10-year median of 5.00)
GF Value™: MXN4,981.98 vs. price of MXN4,775.70 (4.1% below fair value)
Industry Position: 40% above the Medical Devices & Instruments median (#61 of 805)
No single metric tells the full story. See the MEX:PEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
89GF Score
Get the complete analysis for MEX:PEN
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PEN has been successfully added to your 
